Jazz Pharmaceuticals Director Jennifer E. Cook Files Form 144 to Sell $857K in Common Stock
Jazz Pharmaceuticals plc
Subscribe to track JAZZ
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities Issuer: Jazz Pharmaceuticals plc (NASDAQ: JAZZ) Insider: Jennifer E. Cook (Director) Shares Proposed for Sale: 3,507 Estimated Aggregate Market Value: $857,602.00 Approximate Sale Date: 08/31/2026 Broker: E*TRADE Financial Corporation Source of Shares: Restricted Stock Vesting (08/28/2026)
Comprehensive Analysis
Summary of Proposed Insider Sale
- Filer: Jennifer E. Cook, Director of Jazz Pharmaceuticals plc.
- Transaction: Notice of proposed sale under Rule 144 for 3,507 common shares.
- Estimated Value: $857,602.00 (~$244.54 per share based on market value provided).
- Date of Proposed Sale: August 31, 2026.
- Origin of Shares: Acquired on August 28, 2026, through restricted stock vesting as part of equity compensation.
- Broker: E*TRADE Financial Corporation.
- Past 3 Months Activity: Filer reported no other securities sold during the past three months.
Significance
The transaction represents a standard disposition of recently vested equity compensation by an independent director, resulting in low overall market or sentiment impact.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.